The Albumin Excipient Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Albumin Excipient Global Market Report 2025 reveals a strong upward trend. The market size surged from $4.85 billion in 2024 to $5.2 billion in 2025, progressing at a compound annual growth rate (CAGR) of 7.1%.
The Albumin Excipient Global Market is projected to reach $6.77 billion in 2029, with a Compound Annual Growth Rate (CAGR) of 6.8%.
Download Your Free Sample of the 2025 Albumin Excipient Market Report and Uncover Key Trends Now!The key drivers in the albumin excipient market are:
• Continued expansion of the biopharmaceutical sector
• Increase in the pipeline for biologics
• Growth in the geriatric population worldwide
• Increase in global vaccination initiatives and drug development investments
The albumin excipient market covered in this report is segmented –
1) By Product: Human Serum Albumin, Recombinant Albumin
2) By End-Users: Pharmaceutical And Biotechnology Industry, Research Institutes, Other End Users
The key trends in the albumin excipient market are:
• The albumin excipient market is expected to trend towards biodegradable and biocompatible properties.
• There's an emergence of collaborations and partnerships in research within the albumin excipient industry.
• Regulatory compliance and quality standards are defining growth trends in the market.
• An important trend is the increasing application of albumin excipients in cell therapy and the move towards customization and tailored solutions.
The major players in the albumin excipient market are:
• Albumin Therapeutics LLC
• Biotest AG
• CSL Behring
• Grifols S
North America was the largest region in the Albumin Excipient market in 2024